ConductScience.org, home

Paper7208525

Tabular summary of pharmacokinetic parameters relevant to in vitro drug assay.

Alberts DS and 1 other. Prog Clin Biol Res, 1980. Cited by 36 papers, by iCite.

Cite this record

ConductScience Library. Tabular summary of pharmacokinetic parameters relevant to in vitro drug assay. Papers, record 7208525. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7208525

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tabular summary of pharmacokinetic parameters relevant to in vitro drug assay.
PubMed
Journal
Prog Clin Biol Res
PubMed
Year
1980
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
36
iCite
Relative citation ratio, by iCite
1.74
iCite
Revised in PubMed
2004-11-17
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Alberts DSD S
2Chen HSH S

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Cells, Cultured
Clone Cells
Dose-Response Relationship, Drug
Humans
Neoplasms

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.

PMIDTitleJournalYearIn PapersSource
23136592Selection of chemotherapy for glioblastoma expressing O(6)-methylguanine-DNA methyltransferase.Exp Ther Med2010https://conductscience.org/library/papers/23136592PubMed
14612899Promising survival for patients with glioblastoma multiforme treated with individualised chemotherapy based on in vitro drug sensitivity testing.Br J Cancer2003https://conductscience.org/library/papers/14612899PubMed
8944334Heterogeneity of in vitro chemosensitivity in perioperative breast cancer cells to mitoxantrone versus doxorubicin evaluated by a microplate ATP bioluminescence assay.Breast Cancer Res Treat1996https://conductscience.org/library/papers/8944334PubMed
8913836Efficacy of 5'-nor-anhydrovinblastine (vinorelbine), against freshly explanted clonogenic human tumor cells in vitro.Invest New Drugs1996https://conductscience.org/library/papers/8913836PubMed
8272413Histocultures of patient head and neck tumors for pharmacodynamics studies.Pharm Res1993https://conductscience.org/library/papers/8272413PubMed
8018519Activity of cyclosporins as resistance modifiers in primary cultures of human haematological and solid tumours.Br J Cancer1994https://conductscience.org/library/papers/8018519PubMed
7907234Characteristics of the combination paclitaxel plus doxorubicin in breast cancer cell lines analyzed with the ATP-cell viability assay.Breast Cancer Res Treat1993https://conductscience.org/library/papers/7907234PubMed
7749161In vitro activity of taxol and taxotere in comparison with doxorubicin and cisplatin on primary cell cultures of human breast cancers.Breast Cancer Res Treat1995https://conductscience.org/library/papers/7749161PubMed
7499107Adenocarcinoma of unknown primary: retrospective analysis of chemosensitivity of 313 freshly explanted tumors in a tumor cloning system.Invest New Drugs1995https://conductscience.org/library/papers/7499107PubMed
6873970Establishment, characterization, and response to cytotoxic and radiation treatment of three human melanoma cell lines.In Vitro1983https://conductscience.org/library/papers/6873970PubMed
6687222Activity of 4'-0-tetrahydropyranyladriamycin hydrochloride (THP-ADM) in a human tumor cloning system.Invest New Drugs1983https://conductscience.org/library/papers/6687222PubMed
6540761Identification of synergistic combinations of spirogermanium with 5-fluorouracil or cisplatin using a range of human tumour cell lines in vitro.Invest New Drugs1984https://conductscience.org/library/papers/6540761PubMed
6381659Morphologic, cytochemical and neurochemical characterization of the human medulloblastoma cell line TE671.J Neurooncol1984https://conductscience.org/library/papers/6381659PubMed
6380788Cell survival in four ovarian carcinoma xenografts following in vitro exposure to melphalan, cisplatin and cis-diammine-1,1-cyclobutane dicarboxylate platinum II (CBDCA,JM8).Cancer Chemother Pharmacol1984https://conductscience.org/library/papers/6380788PubMed
6357259Hormone supplemented media for cloning human breast cancer: increased colony formation without alteration of chemosensitivity.Br J Cancer1983https://conductscience.org/library/papers/6357259PubMed
6297528Assay of anticancer drugs in tissue culture: cell cultures of biopsies from human astrocytoma.Br J Cancer1983https://conductscience.org/library/papers/6297528PubMed
6190492An assessment of a short-term tumour chemosensitivity assay in chronic lymphocytic leukaemia.Br J Cancer1983https://conductscience.org/library/papers/6190492PubMed
4039488Comparison of the cytotoxic activities of chemotherapeutic drugs using a human bladder cancer cell line.Urol Res1985https://conductscience.org/library/papers/4039488PubMed
3971476Comparison of the cellular pharmacology of doxorubicin in resistant and sensitive models of pancreatic cancer.Cancer Chemother Pharmacol1985https://conductscience.org/library/papers/3971476PubMed
3900924Predictive testing in cancer chemotherapy. II. In vitro.Pharm Weekbl Sci1985https://conductscience.org/library/papers/3900924PubMed

See all 29 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7208525

GET https://conductscience.org/api/papers/v1/7208525/cited_by?page=2